These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7560661)

  • 21. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
    Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
    Derom EY; Pauwels RA
    Thorax; 1992 Jan; 47(1):30-3. PubMed ID: 1539141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The short-term bronchodilator effects of fenoterol and ipratropium in asthma.
    Elwood RK; Abboud RT
    J Allergy Clin Immunol; 1982 May; 69(5):467-73. PubMed ID: 6210726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations.
    Maesen FP; Costongs R; Smeets JJ; Brombacher PJ; Zweers PG
    Chest; 1991 Jun; 99(6):1367-73. PubMed ID: 2036817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
    Dahl R; Creemers JP; Van Noord J; Sips A; Della Cioppa G; Thomson M; Andriano K; Kottakis J; Fashola T
    Respiration; 2004; 71(2):126-33. PubMed ID: 15031566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
    Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
    Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults.
    Conrad SA; Light RW; George RB
    Chest; 1986 Mar; 89(3):394-7. PubMed ID: 3512188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.
    Newnham DM; McDevitt DG; Lipworth BJ
    Am J Med; 1994 Jul; 97(1):29-37. PubMed ID: 7913292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
    Pearlman DS; LaForce CF; Kaiser K
    Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formoterol in the treatment of nocturnal asthma.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Oct; 98(4):866-70. PubMed ID: 1976487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
    Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
    Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.